Member Info for GF123

ATB

Bermuda Good. Me too. At least we are both comfortable with time lines and believe in BOD currently. ATB.

Ruck. Then why believe £8 per share. Only you guys seem to spout that number on some sort of retort to any LTH that is optimistic on sclp. I’m certainly not expecting to sell on £8 and I have a nice number of shares. ATB

Bermuda with significant cash in the bank why does the clock need to be rewound up. Just because the timescale to unwind the IP isn’t as quick as some share holders would like doesn’t mean sclp board would agree that things are not on track. I guess your comments just show your own personal frustrations with delays in your own timescales. Best rewind your own tic rock clock. ATB

Thought you would. ATB

Gazza. Can you read? RNS anyone? It’s a question so I didn’t say an RNS was coming. I’m asking if anyone else thinks there may be one given the odd trades today. But then again you never state the correct position. ATB.

Lots of odd and high value trades going through. RNS anyone? ATB

Ruck $34b v £110m. I’d say it’s pretty obvious. You really do need to think before you post. ATB

Nice delayed buy of 610k of shares. Someone shares my confidence. ATB

Ruck now you are being silly. Scancells IP hasn’t been valued yet and you know it. No shareholder would accept that type of offer. So don’t pretend they would. ATB

feeling confident. ATB

little top up ATB

Lots of buys coming in. News tomorrow? ATB

Very interesting article by Alice Klein in the New Scientist page 38. Can’t post a link as I only have a magazine.

Anyway she discusses how personal cancer vaccines are coming and are targeted so they don’t make people sick - unlike chemo.

She sets out checkpoint inhibitors, car t-cell therapy and personalised vaccines.

Primarily the story is about BioNTech and Moderna who are both conducting trials.

Then Riccardo Dolcetti at the Peter MacCallum Centre in Melbourne questions their approach siting two distinct drawbacks.

First the time it will take to make them and second the cost.

He does stress one of the best things about cancer vaccines is that their targeted nature means that they don’t make people sick, unlike chemotherapy.

If only there was another trial that could target cold tumours and turn them hot. Praveen Aanur, one of Moderna’s chief oncologist is looking at exactly that so that hot tumours can become more susceptible to vaccine treatment.

Dolcetti said “The difficulty is knowing what to target, but several groups around the world are working on this”.

So data data data. Good luck Scancell. I think people are watching.

ATB

Roses. It’s the only negative narrative they have. Let’s face it. Any LTH here knows sclp is as strong as it’s ever been. And (IMO) massively undervalued. So some may wish to twist people arms at this level to sell. I believe, like many, that Sclp is very truly about to transition into something more exciting and profitable for share holders. But let’s see. ATB

Anyone any thoughts on the delayed 1.36m trade yesterday but reported this afternoon? ATB

Davyuk. Well mine was a buy and I paid £8k. Often sells/buys are misrepresented. Anyway good day today. I’ll be happier with more buying pressure and if we can get back above mid 20s. ATB

52,945 Just purchased. I really think this still a bargain price. Roll on more news. ATB

Hasiba. Spike isn’t the right word. News here could change this very very quickly and if trading it, as you do do, you may miss the important rns. I just feel this should be double now. And with news, who knows. Anyway each to their own. ATB

Chelsea. Wake me up at 25p. That’s what it was early last year and we have so much more going on. I think we should be north of 30p easily now. ATB.